BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16681738)

  • 1. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience.
    Selvaggi L; Loizzi V; DI Gilio AR; Nardelli C; Cantatore C; Cormio G
    Int J Gynecol Cancer; 2006; 16(2):631-7. PubMed ID: 16681738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
    Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
    Rose KM; Pham R; Zacharias NM; Ionescu F; Paravathaneni M; Marchetti KA; Sanchez D; Mustasam A; Sandstrom R; Vikram R; Dhillon J; Rao P; Schneider A; Pagliaro L; Alifrangis C; Albersen M; Roussel E; Master VA; Nazha B; Hernandez C; Moses KA; Protzel C; Montgomery J; Angel M; Tobias-Machado M; Spiess PE; Pettaway CA; Chahoud J
    J Natl Cancer Inst; 2024 Jun; 116(6):966-973. PubMed ID: 38366627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer.
    Tian X; Wang X; Cui Z; Liu J; Huang X; Shi C; Zhang M; Liu T; Du X; Li R; Huang L; Gong D; Tian R; Cao C; Jin P; Zeng Z; Pan G; Xia M; Zhang H; Luo B; Xie Y; Li X; Li T; Wu J; Zhang Q; Chen G; Hu Z
    Adv Sci (Weinh); 2021 May; 8(10):2001978. PubMed ID: 34026427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Wang D; Fang X
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():202-208. PubMed ID: 38678796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoimmunotherapy is effective in locally advanced cervical cancer.
    Romero D
    Nat Rev Clin Oncol; 2024 Feb; 21(2):84. PubMed ID: 38110599
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy combined with surgery for the treatment of a rare primary vaginal adenocarcinoma.
    Liu S; Li M; Zhang H
    Asian J Surg; 2024 Apr; 47(4):2039-2040. PubMed ID: 38220528
    [No Abstract]   [Full Text] [Related]  

  • 8. Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer.
    Fu JY; Zhang CP; Zhang ZY
    BMC Cancer; 2021 Jun; 21(1):663. PubMed ID: 34078311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Chemotherapy Alone or Combined with EGFR-Directed Targeted Therapy or Anti-PD-1 Immunotherapy for Locally Advanced Lacrimal Sac and Nasolacrimal Duct Carcinomas.
    Goldfarb J; Fan J; de Sousa LG; Akhave N; Myers J; Goepfert R; Manisundaram K; Zhao J; Frank SJ; Moreno A; Ferrarotto R; Esmaeli B
    Semin Ophthalmol; 2024 Mar; ():1-7. PubMed ID: 38500295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy and Surgery for Cervical Cancer, Timing of Surgery for Esophageal Cancer, Endometrial Cancer Molecular Classification, Vestibular Schwannoma, and Breast Boost Techniques.
    Dover L; Dulaney C
    Pract Radiat Oncol; 2024; 14(1):1-5. PubMed ID: 38182302
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis.
    Vali M; Maleki Z; Nikbakht HA; Hassanipour S; Kouhi A; Nazemi S; Hajizade-Valokolaee M; Nayeb M; Ghaem H
    BMC Womens Health; 2023 Dec; 23(1):671. PubMed ID: 38098009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-Negative Cervical Cancer: A Narrative Review.
    Arezzo F; Cormio G; Loizzi V; Cazzato G; Cataldo V; Lombardi C; Ingravallo G; Resta L; Cicinelli E
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34073478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Treatment of Patients with Metastatic, Recurrent or Persistent Cervical Cancer Not Amenable by Surgery or Radiotherapy: State of Art and Perspectives of Clinical Research.
    Gadducci A; Cosio S
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32961781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the "PRICE" study 2: role of conventional and DW-MRI.
    Gui B; Miccò M; Valentini AL; Cambi F; Pasciuto T; Testa A; Autorino R; Zannoni GF; Rufini V; Gambacorta MA; Giordano A; Scambia G; Manfredi R
    Eur Radiol; 2019 Apr; 29(4):2045-2057. PubMed ID: 30324389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
    Chen Z; Shi Y; Wang S; Lu Q
    Oncotarget; 2017 Aug; 8(35):59609-59617. PubMed ID: 28938664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of the preoperative neoadjuvant chemotherapy for patients with cervical cancer: a systematic review and meta analysis.
    He D; Duan C; Chen J; Lai L; Chen J; Chen D
    Int J Clin Exp Med; 2015; 8(9):14693-700. PubMed ID: 26628951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models.
    Hoch U; Staschen CM; Johnson RK; Eldon MA
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1125-37. PubMed ID: 25228368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in stage IB2 cervical cancer and review of treatment.
    Turan T; Yıldırım BA; Tulunay G; Boran N; Yıldız F; Köse MF
    J Turk Ger Gynecol Assoc; 2010; 11(1):27-37. PubMed ID: 24591891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis.
    Ye Q; Yuan HX; Chen HL
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1887-98. PubMed ID: 24022086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.